Myasthenic crisis and polymyositis induced by one dose of nivolumab

Cancer Science

Volumn 107, Issue 7, 2016, Pages 1055-1058

  Kimura, Toshihiro ^a   Fukushima, Satoshi ^a   Miyashita, Azusa ^a   Aoi, Jun ^a   Jinnin, Masatoshi ^a   Kosaka, Takayuki ^a   Ando, Yukio ^a   Matsukawa, Masakazu ^b   Inoue, Hiroyuki ^c   Kiyotani, Kazuma ^c   Park, Jae Hyun ^c   Nakamura, Yusuke ^c   Ihn, Hironobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Melanoma; myasthenia gravis; myositis; nivolumab; tumor infiltrating lymphocyte

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHOLINERGIC RECEPTOR ANTIBODY; CREATINE KINASE; DACARBAZINE; GZMA PROTEIN; IMMUNOGLOBULIN; NIVOLUMAB; PREDNISOLONE; PRF1 PROTEIN; PROTEIN; PYRIDOSTIGMINE; STEROID; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

AGED; ANOREXIA; ANTIBODY BLOOD LEVEL; APNEA; ARTICLE; AUTOIMMUNE DISEASE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CONSERVATIVE TREATMENT; CREATINE KINASE BLOOD LEVEL; CUTANEOUS MELANOMA; CYTOTOXIC T LYMPHOCYTE; DRUG PULSE THERAPY; DYSPNEA; ECHOCARDIOGRAPHY; FATIGUE; GENE EXPRESSION; HUMAN; IMMUNE ABSORPTION THERAPY; IMMUNE RESPONSE; IMMUNOTHERAPY; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAINTENANCE THERAPY; MALE; MONOTHERAPY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYASTHENIA; MYASTHENIA GRAVIS; MYASTHENIC CRISIS; MYOCARDITIS; MYOSITIS; NEXT GENERATION SEQUENCING; PLASMAPHERESIS; POLYMYOSITIS; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION; SINGLE DRUG DOSE; SKIN METASTASIS; SKIN SURGERY; STEROID THERAPY; T LYMPHOCYTE; TH1 TH2 BALANCE; VERY ELDERLY;

EID: 84978858528     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12961     Document Type: Article

References (6)

1. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363: 711–23.
2. Larkin J, Hodi FS, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 2015; 373: 1270–1.
3. Fang H, Yamaguchi R, Liu X, et al. Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor α and β chains using next-generation sequencing (NGS). Oncoimmunology 2014; 3: e968467.
4. Shirai T, Sano T, Kamijo F, et al. Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma. Jpn J Clin Oncol 2016; 46: 86–8.
5. Yoshioka M, Kambe N, Yamamoto Y, Suehiro K, Matsue H. Case of respiratory discomfort due to myositis after administration of nivolumab. J Dermatol 2015; 42: 1008–9.
6. Suzuki S, Utsugisawa K, Yoshikawa H, et al. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol 2009; 66: 1334–8.